<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">350807</id>
  <title nil="true"/>
  <common-name>N-[3-(4-benzylpiperazin-1-yl)-2-hydroxypropyl]-4-methyl-n-(2-prop-2-enoxyphenyl)benzenesulfonamide</common-name>
  <description>N-[3-(4-benzylpiperazin-1-yl)-2-hydroxypropyl]-4-methyl-n-(2-prop-2-enoxyphenyl)benzenesulfonamide has the chemical formula C30H37N3O4S. With an average molecular weight of 535.70 g/mol, N-[3-(4-benzylpiperazin-1-yl)-2-hydroxypropyl]-4-methyl-n-(2-prop-2-enoxyphenyl)benzenesulfonamide is a heavy molecule.</description>
  <cas>77557-39-2</cas>
  <pubchem-id>3059989</pubchem-id>
  <chemical-formula>C30H37N3O4S</chemical-formula>
  <weight>535.7</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T16:06:23Z</created-at>
  <updated-at type="dateTime">2026-08-31T16:06:23Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC1=CC=C(C=C1)S(=O)(=O)N(CC(CN2CCN(CC2)CC3=CC=CC=C3)O)C4=CC=CC=C4OCC=C</moldb-smiles>
  <moldb-formula>C30H37N3O4S</moldb-formula>
  <moldb-inchi>InChI=1S/C30H37N3O4S/c1-3-21-37-30-12-8-7-11-29(30)33(38(35,36)28-15-13-25(2)14-16-28)24-27(34)23-32-19-17-31(18-20-32)22-26-9-5-4-6-10-26/h3-16,27,34H,1,17-24H2,2H3</moldb-inchi>
  <moldb-inchikey>MQURHQICQJJARX-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">535.2504778</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>4.3</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM346700</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>N-[3-(4-benzylpiperazin-1-yl)-2-hydroxypropyl]-4-methyl-n-(2-prop-2-enoxyphenyl)benzenesulfonamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Benzenoids</superklass>
  <klass>Benzene and substituted derivatives</klass>
  <subklass>Toluenes</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0301111</sync-id>
  <structure-inchikey>MQURHQICQJJARX-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>400000000004000000208000000000000000000000000000000000001010000000000000000000010000000200000000040000000000000000000000000000000000000000800000000000000000020000200000000003000010000000000000000080000101000000000000000040000000000211080000000000000000000000000000402000008000000000000000000080000001000000000000000000000000000000000000000022000800000020000000000800000980400000000000100000000000000000100010000400000000180000000020000002200410000100000001000000000800400000000000a0000020100020000000000020000200</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAmAAAAKQAAAIABBgBgAAAAAQMGQCgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:48:46Z</structure-indexed-at>
</compound>
